There is a mutation of a gene coding for the ryanodine receptors in malignant hyperthermia. Which of the following statements best explains the increased heat production in malignant hyperthermia?
**Core Concept**
Malignant hyperthermia (MH) is a life-threatening medical emergency triggered by certain anesthetics, characterized by an abnormal increase in muscle heat production. The condition is associated with mutations in the genes encoding for ryanodine receptors (RyR), which play a crucial role in regulating calcium release from the sarcoplasmic reticulum.
**Why the Correct Answer is Right**
Ryanodine receptors are calcium channels that release calcium ions from the sarcoplasmic reticulum into the muscle cell cytosol. In normal conditions, these receptors are regulated by a feedback mechanism that prevents excessive calcium release. However, mutations in the RyR gene can disrupt this regulation, leading to abnormal calcium release and an increase in muscle heat production. This excessive calcium release triggers a series of downstream events, including an increase in ATP production, which in turn leads to an increase in heat production.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the pathophysiology of malignant hyperthermia. While it is true that anesthetics can trigger MH, the underlying cause is the genetic mutation of the RyR gene, not the anesthetic itself.
**Option B:** This option is incorrect because it does not accurately describe the role of calcium in malignant hyperthermia. While calcium is involved in the regulation of muscle contraction and relaxation, the increased heat production in MH is a result of excessive calcium release from the sarcoplasmic reticulum, not a decrease in calcium levels.
**Option C:** This option is incorrect because it does not accurately describe the relationship between ATP production and heat production in malignant hyperthermia. While it is true that ATP production increases in MH, this increase is a result of excessive calcium release and an increase in muscle metabolism, not a direct result of ATP production itself.
**Clinical Pearl / High-Yield Fact**
The diagnosis of malignant hyperthermia can be confirmed by measuring the levels of creatine kinase (CK), a muscle enzyme that is released into the bloodstream in response to muscle damage. Elevated levels of CK are a hallmark of MH, and this test can be used to differentiate MH from other causes of hyperthermia.
**Correct Answer:** C. Excessive calcium release from the sarcoplasmic reticulum leads to an increase in ATP production, resulting in increased heat production in malignant hyperthermia.